Forschungsdatenbank

Projektübersicht
Login
Suche

Hossle

Fakultäten » Medizinische Fakultät » Kinderspital Zürich: Medizinische Klinik » Immunologie, Abteilung » Prof. Dr. Reinhard Seger » Hossle

Completed research project

Title / Titel Development of clinically applicable protocols for transitory and permanent somatic gene therapy in chronic granulomatous disease
PDF Abstract (PDF, 14 KB)
Summary / Zusammenfassung The objective of our study was the development of clinically applicable protocols for somatic gene therapy in patients with the X-linked primary immunodeficiency chronic granulomatous disease (X-CGD).
We have developed a bicistronic retroviral vector (SPsLdS) carrying the therapeutic gp91phox gene and a truncated form of the low affinity nerve growth factor receptor (DLNGFR) as a selectable marker. Using this vector, transduction of CD34+ bone marrow (BM) cells or mobilized peripheral blood CD34+ cells (PBSC) from X-CGD patients resulted in clinically relevant levels of functional correction of X-CGD.
The long-term function of SPsLdS was successfully evaluated in the X-CGD knock-out mouse model.
Mobilized human CD34+ PBSC transduced with the SPsLdS retroviral vector were successfully tested for engraftment in the NOD/SCID mouse model.
The developed retroviral vector SPsLdS was produced under good-manufacturing-practise (GMP) conditions, and has been approved to be used in a clinical phase I study.
Most recent further progress included i) lentiviral vector constructs for gene transfer into even more primitive quiescent stem cells and ii) successful assembly of a human G-CSFR/estrogen chimeric receptor for to provide transduced progenitor cells with a selection advantage.
Publications / Publikationen Becker S, S Wasser, M Hauses, JP Hossle, MG Ott, MC Dinauer, A Ganser, D Hoelzer, R Seger, and M Grez. 1998. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum. Gen. Ther. 9:1561-1570.

Schneider SD, S Rusconi, RA Seger, and JP Hossle. 1997. Adenovirus-mediated gene transfer into monocyte-derived macrophages of patients with X-linked chronic granulomatous disease: ex vivo correction of deficient respiratory burst. Gene Therapy 4:524-532.

Schwarz K, S Nonoyama, MC Peitsch, G de Saint Basile, T Espanol, A Fasth, A Fischer, K Freitag, W Friedrich, S Fugmann, JP Hossle, A Jones, C Kinnon, A Meindl, L Notarangelo, A Wechsler, M Weiss, HD Ochs. 1996. WASPbase: a database of mutations causing the Wiskott-Aldrich Syndrome (WAS) and X-linked Thrombocytopenia (XLT). Immunology Today 17:496-502.

Keywords / Suchbegriffe Chronic granulomatous disease (CGD), phagocytes, bone marrow cells, retroviral vector, somatic gene therapy
Project leadership and contacts /
Projektleitung und Kontakte
Dr. sc. nat. J.P. Hossle (Project Leader) hosslejp@kispi.uzh.ch
Prof. R. Seger rseger@kispi.uzh.ch
Other links to external web pages http://www.unifr.ch/nfp37/
In collaboration with /
In Zusammenarbeit mit
Dr. Manuel Grez
Georg-Speyer-Haus
Paul-Ehrlich-Str. 42-44
D-60596 Frankfurt a.M.
Germany

Mary C. Dinauer, MD, PhD
Department of Pediatrics and Medical and Molecular Genetics
Indiana University School of Medicine
Herman B Wells Center for Pediatric Research
James Whitcomb Riley Hospital for Children
Cancer Research Institute, R4 466
1044 West Walnut Indianapolis, IN 46202-5225

United States

Adrian Thrasher, MD, PhD
Molecular Immuology Unit
Institute of Child Health
30 Guilford Street
London WCIN IEH

United Kingdom

Duration of Project / Projektdauer Oct 1996 to Jun 2000